Potential mechanisms of susceptibility to periodontitis in tobacco smokers

Journal of Periodontal Research

Volumn 34, Issue 7, 1999, Pages 363-369

  Palmer, R M ^a   Scott, D A ^a   Meekin, T N ^a   Poston, R N ^a   Odell, E W ^a   Wilson, R F ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Adhesion molecules; Laser Doppler flowmetry; Periodontitis; Smoking

Indexed keywords

COTININE; INTERCELLULAR ADHESION MOLECULE 1; NICOTINE; NICOTINIC AGENT;

BLOOD; BLOOD FLOW; DISEASE PREDISPOSITION; FOREHEAD; GINGIVA; HUMAN; LASER DOPPLER FLOWMETRY; PATHOPHYSIOLOGY; PERIODONTITIS; PHYSIOLOGY; REVIEW; RISK FACTOR; SKIN; SMOKING; TIME; VASCULARIZATION; VASOCONSTRICTION;

COTININE; DISEASE SUSCEPTIBILITY; FOREHEAD; GINGIVA; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LASER-DOPPLER FLOWMETRY; NICOTINE; NICOTINIC AGONISTS; PERIODONTITIS; REGIONAL BLOOD FLOW; RISK FACTORS; SKIN; SMOKING; TIME FACTORS; VASOCONSTRICTION;

EID: 0033202269     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.1999.tb02267.x     Document Type: Article

References (65)

1. Bergström J. Cigarette smoking as a risk factor in chronic periodontal disease. Commun Dent Oral Epidemiol 1989;17:245-247.
2. Grossi SG, Skrepcinski FB, DeCaro T, Zambon JJ, Cummins D, Genco RJ. Response to periodontal therapy in diabetics and smokers. J Periodontol 1996;67:1094-1102.
3. Hart TC, Kornman KS. Genetic factors in the pathogenesis of periodontitis. Periodontol 2000 1997;14:202-215.
4. Ah MK, Johnson GK, Kaldahl WB, Patil KD, Kalkwarf KL. The effect of smoking on the response to periodontal therapy. J Clin Periodoniol 1994;21:91-97.
5. Palmer RM, Matthews JP, Wilson RF. Non-surgical periodontal treatment with and without adjunctive metronidazole in smokers and non-smokers. J Clin Periodontol 1999;26:158-163.
6. Ismail AI, Bert BA, Ekland SA. Epidemiologic patterns of smoking and periodontal disease in the United States. J Am Dent Assoc 1983;106:617-621.
7. Kaldahl WB, Johnson GK, Patil K, Kalkwarf KL. Levels of cigarette consumption and response to periodontal therapy. J Periodontol 1996;67:675-681.
8. Haber J. Cigarette smoking: a major risk factor for periodontitis. Compend Contin Educ Dent 1994;15: 1002-1008.
9. Barbour SE, Nakashima K, Zhang JB et al. Tobacco and smoking: environmental factors that modify the host response (immune system) and have an impact on periodontal health. Crit Rev Oral Biol Med 1997;8:437-460.
10. Benowitz NL. Pharmacology of nicotine: addiction and therapeutics. Ann Rev Pharmacol Toxicol 1996;36:597-613.
11. Haber J. Smoking is a major risk factor for periodontitis. Curr Opin Periodontol 1994;12-18.
12. MacNee W, Drost E. Cigarette smoking and neutrophil trafficking in the lungs. Biologist 1997;44:366-368.
13. Mazzoni MC, Schmid-Schonbein GW. Mechanisms and consequences of cell activation in the microcirculation. Cardiovasc Res 1996;32:709-719.
14. Palmer RM. Effect of smoking in periodontal disease. In: Palmer RM. Tobacco smoking and oral health, occasional paper 6. UK: Health Education Authority, 1987:4-8.
15. Powell JT. Vascular damage from smoking: disease mechanisms at the arterial wall. Vasc Med 1998;3:21-28.
16. Jarvis MJ, Tunstall-Pedoe H, Feyerabend C. Vesey C, Saloojee Y. Comparison of tests used to distinguish smokers from non-smokers. Am J Publ Health 1987;77: 1435-1438.
17. Meekin TN, Wilson RF, Scott DA, Ide M, Palmer RM. Laser Doppler flowmeter measurement of relative gingival and forehead skin blood flow in light and regular smokers during and after smoking. J Clin Periodontol 1999; in press.
18. Russell MAH, Jarvis M, Iyer R, Feyerabend C. Relation of nicotine yield of cigarettes to blood nicotine concentrations in smokers. Br Med J 1980;280:972-976.
19. Gonzalez YM, de Nardin A, Grossi SG, Machtei EE, Genco RJ, de Nardin E. Serum cotinine levels, smoking and periodontal attachment loss. J Dent Res 1996;75: 796-802.
20. Machtei EE, Dunford R, Hausmann E et al. Longitudinal study of prognostic factors in established periodontitis patients. J Clin Periodontol 1997;24:102-109.
21. Clarke NG, Shepherd BC, Hirsch RS. The effects of intraarterial epinephrine and nicotine on gingival circulation. Oral Surg Oral Med Oral Pathol 1981;52:577-582.
22. Baab DA, Öberg PA. The effect of cigarette smoking on gingival blood flow in humans. J Clin Periodontol 1987; 14:418-424.
23. Lekakis J, Papamichael C, Vemmos C et al. Effect of acute cigarette smoking on endothelium-dependent brachial artery dilatation in healthy individuals. Am J Cardiol 1997;79:529-531.
24. Russell MAH, Feyerabend C, Cole PV. Plasma nicotine levels after cigarette smoking and chewing nicotine gum. Br Med J 1976;1:1043-1046.
25. 3H]nicotine binding in human postmortem brain. J Pharmacol Exp Ther 1997;282:7-13.
26. Olale F, Gerzanich V, Kuryatov A, Wang F, Lindstrom J. Chronic nicotine exposure differentially affects the function of human alpha3, alpha4, and alpha7 neuronal nicotinic receptor subtypes. J Pharmacol Exp Ther 1997;283:675-683.
27. Bergström J, Preber H. The influence of cigarette smoking on the development of experimental gingivitis. J Periodont Res 1986;21:668-676.
28. Brill N, Björn H. Passage of tissue fluid into human gingival pockets. Acta Odont Scand 1959;17:11-21.
29. McLaughlin WS, Lovat FM, Macgregor ID, Kelly PJ. The immediate effects of smoking on gingival fluid flow. J Clin Periodontol 1993;20:448-451.
30. van de Stolpe A, van der Saag PT. Intercellular adhesion molecule-1. J Mol Med 1996;74:13-33.
31. Crawford JM. The distribution of ICAM-1, LFA-3 and HLA-DR in healthy and diseased gingival tissues. J Periodont Res 1993;28:145-151.
32. Crawford JM, Watanabe K. Cell adhesion molecules in inflammation and immunity: relevance to periodontal diseases. Crit Rev Oral Biol Med 1994;5:91-123.
33. Koundouros E, Odell E, Coward PY, Wilson RF, Palmer RM. Soluble adhesion molecules in serum of smokers and non-smokers, with and without periodontitis. J Periodont Res 1996;31:596-599.
34. Wakatsuki T, Kimura K, Kimura F et al. A distinct mRNA encoding a soluble form of ICAM-1 molecule expressed in human tissues. Cell Adhes Commun 1995;3:283-292.
35. Budnik A, Grewe M, Gyufko K, Krutmann J. Analysis of the production of soluble ICAM-1 molecules by human cells. Exp Hematol 1996;24:352-359.
36. Inuzuka H, Seita T, Okomato K, Iida K, Ogawa Y, Iwasa S. A sensitive ELISA for the characterization of two forms of circulating intercellular adhesion molecule-1 in human plasma. Biol Pharm Bull 1995;18:1036-1040.
37. Miller J, Knorr R, Ferrone M, Houdei R, Carron CP, Dustin ML. Intercellular adhesion molecule-1 dimerization and its consequences for adhesion mediated by lymphocyte function associated antigen-1. J Exp Med 1995;182: 1231-1241.
38. Reilly PL, Woska Jr JR, Jeanfavre DD, McNally E, Rothlein R, Bormann BJ. The native structure of intercellular adhesion molecule-1 (ICAM-1) is a dimer. Correlation with binding to LFA-1. J Immunol 1995;155: 529-532.
39. Seth R, Raymond FD, Makgoba MW. Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders. Lancet 1991;338:83-84.
40. Kalra VK, Ying Y, Deemer K, Natarajan R, Nadler JL, Coates TD. Mechanism of cigarette smoke condensate induced adhesion of human monocytes to cultured endothelial cells. J Cell Physiol 1994;160:154-162.
41. Adams MR, Jessup W, Celermajer DS. Cigarette smoking is associated with increased human monocyte adhesion to endothelial cells: reversibility with oral L-arginine but not vitamin C. J Am Coll Cardiol 1997;29:491-497.
42. Weber C, Erl W, Weber K, Weber PC. Increased adhesiveness of isolated monocytes to endothelium is prevented by vitamin C intake in smokers. Circulation 1996;93:1488-1492.
43. Pitzer JE, Del Zoppo GJ, Schmid-Schönbein GW. Neutrophil activation in smokers. Biorheology 1996;33: 45-58.
44. Rothlein R, Mainolfi EA, Czajkowski M, Marlin SD. A form of circulating ICAM-1 in human serum. J Immunol 1991;147:3788-3793.
45. Woska Jr JR, Morelock MM, Jeanfavre DD, Caviness GO, Bormann BJ, Rothlein R. Molecular comparison of soluble intercellular adhesion molecule (sICAM)-1 and sICAM-3 binding to lymphocyte function-associated antigen-1. J Biol Chem 1998;273:4725-4733.
46. Rieckmann P, Michel U, Albrecht M, Bruck W, Wockel L. Felgenhauer K. Soluble forms of intercellular adhesion molecule-1 (ICAM-1) block lymphocyte attachment to cerebral endothelial cells. J Neuroimmunol 1995;60:9-15.
47. Watanabe K, Blew B, Scherer M, Koh G, Block C, Ramakrishnan V. CD11b mRNA expression in neutrophils isolated from peripheral blood and gingival crevicular fluid. J Clin Periodontol 1997;24:814-822.
48. Watanabe K, Hagen KL, Ramakrishnan V, Anderesen BR. Kinetics of CD11b expression on neutrophils isolated from subjects with healthy gingivae and patients with advanced periodontitis. J Periodont Res 1993;28:137-144.
49. Molé N, Kennel-de March A, Martin G, Miller N. Béné MC, Faure GC. High levels of soluble intercellular adhesion molecule-1 (ICAM-1) in crevicular fluid of periodontitis patients with plaque. J Clin Periodontol 1998;25:754-758.
50. Barnett CC, Moore EE, Moore FA, Biffl WL, Partrick DA. Soluble intercellular adhesion molecule-1 provokes polymorphonuclear leukocyte elastase release by CD18. Surgery 1996;120:395-402.
51. Alavi AL, Palmer RM, Odell EW, Coward PY, Wilson RF. Elastase in gingival crevicular fluid from smokers and non-smokers with chronic inflammatory periodontal disease. Oral Dis 1995;1:103-105.
52. Eichel BL, Shahrik HA. Tobacco smoke toxicity: loss of human oral leukocyte function and fluid-cell metabolism. Science 1969;166:1424-1428.
53. Kraal JE, Kenney EB. The response of polymorphonuclear leukocytes to chemolactic stimulation for smokers and non-smokers. J Periodont Res 1979;14:383-389.
54. Gearing AJH, Newman W. Circulating adhesion molecules in disease. Immunol Today 1994;14:506-512.
55. Furukawa S, Motohashi T, Matsubara T, Imai K, Okomura K, Yabuta K. Soluble ICAM-1 levels in serum during acute infectious mononucleosis. Scand J infect Dis 1993;25:249-252.
56. Shijubo N, Imai K, Shigehara K et al. Soluble intercellular adhesion molecule-1 (ICAM-1) in sera and bronchoalveolar lavage (BAL) fluids of extrinsic allergic alveolilis. Clin Exp Immunol 1995;102:91-97.
57. Sfikakis PP, Charalambopoulos D, Vayiopoulos G, Oglesby R, Sfikakis P, Tsokos GC. Increased levels of intercellular adhesion molecule-1 in the serum of patients with systemic lupus erythematosus. Clin Exp Rheumatol 1994;12:5-9.
58. Kobayashi T, Hashimoto S, Isma K, Amemiya E, Yamaguchi M, Horie T. Elevation of serum soluble intercellular adhesion molecule-1 (sICAM-1) and sE-selectin levels in bronchial asthma. Clin Exp Immunol 1994;96: 110-115.
59. Griffiths CE, Boffa MJ, Gallatin WM, Martin S. Elevated levels of circulating adhesion molecule-3 (cICAM-3) in psoriasis. Acta Derm Venereol 1996;76:2-5.
60. Krejsek J, Slezák R, Kopecky O, Derner V, Andrys C. Elevation of serum soluble intercellular adhesion molecule-1 (sICAM-1) and beta-2-microglobulin in Sjögren's syndrome. Clin Rheumatol 1997;16:149-153.
61. Goke M, Hoffmann JC, Evers J, Kruger H, Manns MP. Elevated serum concentrations of soluble selectin and immunoglobulin type adhesion molecules in patients with inflammatory bowel disease. J Gastroenterol 1997;32: 480-486.
62. De Rose V, Oliva A, Messore B, Grosso B, Mollar C, Pozzi E. Circulating adhesion molecules in cystic fibrosis. Am J Respir Crit Care Med 1998;157:1234-1239.
63. Grothey A, Heistermann P, Philippou S, Voigtmann R. Serum levels of soluble intercellular adhesion molecule-1 (ICAM-1, CD54) in patients with non-small-cell lung cancer: correlation with histological expression of ICAM-1 and tumour stage. Br J Cancer 1998;77:801-807.
64. Blann AD, Seigneur M, Steiner M, Miller JP, McCollum CN. Circulating ICAM-1 and VCAM-1 in peripheral artery disease and hypercholesterolaemia: relationship to the location of atherosclerotic disease, smoking, and in the prediction of adverse events. Thromb Haemost 1998;79: 1080-1085.
65. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998;351:88-92.